ns-MRAs and Biomarkers: The NT-proBNP Connection
- Author
- ReachMD
- Published
- Fri 10 Jan 2025
- Episode Link
- http://reachmd.com/programs/cme/ns-mras-and-biomarkers-the-nt-probnp-connection/30064/
CME credits: 1.25
Valid until: 10-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/ns-mras-and-biomarkers-the-nt-probnp-connection/30064/
Valid until: 10-01-2026
Claim your CME credit at https://reachmd.com/programs/cme/ns-mras-and-biomarkers-the-nt-probnp-connection/30064/
Discover the transformative potential of nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs) in optimizing care for patients with the Cardiovascular-Kidney-Metabolic syndrome. Emerging data presented at EASD, HFSA, ASN and AHA, highlight their ability to improve cardiorenal outcomes in the spectrum of the Cardiovascular-Kidney-Metabolic syndrome. By integrating ns-MRAs into individualized treatment plans, healthcare professionals can offer their patients advanced care backed by cutting-edge research.
